This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment鈥�
- Investigator
- Tithi Biswas
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All